|
|
| Research article summary (published 7 Oct 2009): |
Update on influenza A (H1N1) 2009 monovalent vaccines.
Full Abstract
On September 15, 2009, four influenza vaccine manufacturers received approval from the Food and Drug Administration for use of influenza A (H1N1) 2009 monovalent influenza vaccines in the prevention of influenza caused by the 2009 pandemic influenza A (H1N1) virus. Both live, attenuated and inactivated influenza A (H1N1) 2009 monovalent vaccine formulations are available; each contains the strain A/California/7/2009(H1N1)pdm. None of the approved influenza A 2009 (H1N1) monovalent vaccines or seasonal influenza vaccines contains adjuvants. CDC's Advisory Committee on Immunization Practices has made recommendations previously for which persons should be the initial targets for immunization with influenza A (H1N1) 2009 monovalent vaccines and has issued guidelines on decisions for expansion of vaccination efforts to other population groups. Children aged 6 months--9 years receiving influenza A (H1N1) 2009 monovalent vaccines should receive 2 doses, with doses separated by approximately 4 weeks; persons aged >or=10 years should receive 1 dose.
Author information
Author/s: Centers for Disease Control and Prevention (CDC);
Journal and publication information
Publication Type: Journal Article
Journal: MMWR. Morbidity and mortality weekly report (MMWR Morb Mortal Wkly Rep), published in United States. (Language: eng)
Reference: 2009-Oct; vol 58 (issue 39) : pp 1100-1
Dates: Created 2009/10/09; Completed 2009/10/14;
PMID: 19816398, status: MEDLINE (last retrieval date: 10/14/2009, IMS Date: )
Sourced from the National Library of Medicine. Abstract text and other information may be subject to copyright.
External Links for this article
(including full text providers, if available):
Click Electronic Full-text Provider Links to see options for finding the electronic full text links to this article. Note there may be a subscription or fee required for access to the full text. See our FAQ for information on finding FREE full text articles.
This article may also be located in paper journal collections available in many libraries. Use the Journal and Publication Information above to find the full article.
MeSH headings (categories)
This article was linked to the MESH Headings shown below.
Related articles
These are the highest related articles currently in the database:
- Cellular immune responses in children and adults receiving inactivated or live attenuated influenza vaccines.
11 Sep 2006 - Effectiveness of virosomal subunit influenza vaccine in preventing influenza-related illnesses and its social and economic consequences in children aged 3-14 years: a prospective cohort study.
4 Jun 2006 - [Advantages and disadvantages of inactivated and live influenza vaccine]
29 Jun 2004 - Demystifying FluMist, a new intranasal, live influenza vaccine.
30 Aug 2003 - Immunogenicity and safety of inactivated influenza virus vaccine in young children in 2003-2004.
29 Sep 2005 - Recent changes in influenza epidemiology and vaccination recommendations.
30 Dec 2004 - [Influenza vaccine]
29 Apr 2005 - Leads from the MMWR. Recommendations of the Immunization Practices Advisory Committee. Monovalent influenza A(H1N1) vaccine, 1986-1987.
Oct 1986 - Monovalent influenza A(H1N1) vaccine, 1986-1987.
13 Aug 1986 - Comparison of the efficacy and safety of live attenuated cold-adapted influenza vaccine, trivalent, with trivalent inactivated influenza virus vaccine in children and adolescents with asthma.
29 Sep 2006
Related Article Map
Legend:
- FREE Full text Article.
- Abstract only.
- Title only. More help.
See a large map of 100+ related articles.